Cystic Fibrosis
1,360
81
120
937
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
294 trials with published results (22%)
Research Maturity
937 completed trials (69% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.0%
109 terminated out of 1360 trials
89.6%
+3.0% vs benchmark
16%
220 trials in Phase 3/4
31%
294 of 937 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 937 completed trials
Clinical Trials (1360)
Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis
Impact of Telerehabilitation Training on Pediatric Cystic Fibrosis Patients: An Exploratory Study
Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis
Natural History of Noncirrhotic Portal Hypertension
HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
Role of Genetic Factors in the Development of Lung Disease
Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants
A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa
Natural History of Bronchiectasis
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
High Resolution Micro OCT Imaging
Osteopathic Treatment in Adult Patients With Cystic Fibrosis
Quantitation and Spatial Registration of Airways Dysfunction With Dynamic 19F MRI in Cystic Fibrosis
Volatilomic Approaches for the Study of CFTR Modulators (VOLATIL-CF)
Early Check: Expanded Screening in Newborns